1. P.040 Value-based approach to the management of Inflammatory Neuropathies: Incorporating objective outcome measures in clinical care. (June 2022) Authors: Smith, CB; Chapman, K; Mezei, M; Beadon, K Journal: Canadian journal of neurological sciences Issue: Volume 49(2022)Supplement 1 Page Start: S18 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P.048 Objective measures of balance deficits in sensory ganglionopathy. (June 2022) Authors: Smith, CB; Beadon, K; Berger, M; Carpenter, M; Washbrook, C; Chapman, KM Journal: Canadian journal of neurological sciences Issue: Volume 49(2022)Supplement 1 Page Start: S20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P.056 Optimizing IVIg Use for Neuromuscular Conditions in British Columbia, Canada – Targeting High and Chronic User Groups. (November 2021) Authors: Chapman, K; Beauchamp, A; Moisa Popurs, M; Mosewich, R; Beadon, K Journal: Canadian journal of neurological sciences Issue: Volume 48(2021)Supplement S3 Page Start: S35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P.060 Immunoglobulin Use For Neuromuscular Conditions: Updating British Columbia Provincial Guidelines Through Focused Literature Review. (November 2021) Authors: Tse, EK; Smith, CB; Chapman, KM; Beadon, K Journal: Canadian journal of neurological sciences Issue: Volume 48(2021)Supplement S3 Page Start: S35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P.091 Consensus Guidelines for Utilization and Monitoring of Intravenous Immunoglobulin for Central Nervous System Disorders in British Columbia. (November 2021) Authors: Uy, CE; Cross, HM; Percy, J; Schrader, D; Carruthers, R; Traboulsee, A; Beauchamp, A; Shih, AW; Morrison, D; Chapman, KM; Beadon, K Journal: Canadian journal of neurological sciences Issue: Volume 48(2021)Supplement S3 Page Start: S45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P.108 Use of intravenous immunoglobulin for central nervous system disorders in British Columbia: consensus guidelines. (June 2022) Authors: Uy, C; Cross, HM; Percy, J; Schrader, D; Carruthers, R; Traboulsee, A; Beauchamp, A; Shih, A; Morrison, D; Chapman, K; Beadon, K Journal: Canadian journal of neurological sciences Issue: Volume 49(2022)Supplement 1 Page Start: S36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗